We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Researchers Culture Novel Three-Dimensional Artificial Tumors

By LabMedica International staff writers
Posted on 07 Dec 2015
Print article
Image: This rolled-up strip of engineered tissue allows researchers to mimic the way cells grow in a tumor, yet it can be unrolled in seconds for detailed analysis (Photo courtesy of Darren Rodenhizer, University of Toronto Engineering).
Image: This rolled-up strip of engineered tissue allows researchers to mimic the way cells grow in a tumor, yet it can be unrolled in seconds for detailed analysis (Photo courtesy of Darren Rodenhizer, University of Toronto Engineering).
A team of Canadian cancer researchers has developed a novel method for growing three-dimensional cultures of cancer cells that behave as artificial tumors and which can be readily resolved to evaluate the response of individual cells to different levels of oxygen and nutrients.

The cells growing in the center of a tumor have reduced access to oxygen and nutrients as compared to those growing near the surface, nearer to blood vessels. These subtle, location-dependent environment differences influence cell behavior, but their effect has proven difficult to replicate in laboratory culture.

Investigators at the University of Toronto (ON, Canada) have reported the development of a novel culture system in the form of a rolled-up sheet that mimics the three-dimensional environment of a tumor, yet can also be taken apart in seconds.

The investigators impregnated a short strip of a porous, paper-like support material with collagen and cancer cells. The strip was then incubated for 24 hours in a nutrient-rich culture solution, which allowed the cells to adjust to their new environment. The strip was then rolled around a metal core, forming an artificial tumor, which was then cultured for several more days before performing analysis of tumor cell behavior. By unrolling the strip, the model could be rapidly disassembled for snapshot analysis, allowing spatial mapping of cell metabolism in concert with cell phenotype.

Results published in the November 23, 2015, online edition of the journal Nature Materials revealed that as the oxygen level decreased in internal areas of the tumor roll, the number of dead cells increased, which indicated that the cells had responded to the oxygen gradient.

Cells able to live under hypoxic conditions were found to behave differently than the surface cells: for example, they more strongly expressed genes associated with low oxygen conditions. Changes in gene expression, as determined by liquid chromatography tandem mass spectrometry metabolic signature analysis, were gradual and continuous along the length of the strip.

Senior author Dr. Alison McGuigan, professor of chemical engineering at the University of Toronto, said, "The technology holds great promise for the field of personalized medicine. The idea would be to take a patient's own cells and create copies of their tumor. These copies could then be subjected to various treatments and analyzed by the simple unrolling process, providing information about what is likely to work best for that specific patient. It is very translatable and transferable to other labs. We definitely want others to use it, because the larger the community, the more applications we will discover."

Related Links:
University of Toronto


New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Automatic Nucleic Acid Extractor
GeneRotex 24

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The new tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells (Photo courtesy of Christian Stolte/Weill Cornell)

Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods

Liquid biopsy technology has yet to fully deliver on its significant potential. Traditional methods have focused on a narrow range of cancer-associated mutations that are often present in such low quantities... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
LGC Clinical Diagnostics